For patients with major depressive disorder (MDD), durable remission—both in terms of symptom control and functional ability—is the penultimate therapeutic goal.(1) Striving for attainment of this goal is paramount. It means that clinicians must be outfitted with tools and strategies and must know how to use them in a manner that balances optimal efficacy with safety and tolerability.